Evidence map›Paper›PMID 28226002›Full record

ArticleArchives of endocrinology and metabolism

Serum levels of leptin and adiponectin and clinical parameters in women with fibromyalgia and overweight/obesity.

Eduardo S Paiva, Aline Andretta, Emmanuelle Dias Batista, Márcia Maria Marques Teles Lobo, Renata Costa de Miranda, Renato Nisihara, Maria Eliana Madalozzo Schieferdecker, César L Boguszewski

Open access · diamondAbstract read
In one paragraph

Article in Archives of endocrinology and metabolism. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Musical therapy attenuates neuroma pain by modifying leptin expression.BMC complementary medicine and therapies · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Adiponectin in Myopathies.International journal of molecular sciences · 2019
    Review
  16. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Eduardo S PaivaDepartamento de Medicina Interna, Universidade Federal do Paraná (UFPR), Curitiba, PR, Brasil.
Aline AndrettaDepartamento de Nutrição, UFPR, Curitiba, PR, Brasil.
Emmanuelle Dias BatistaDepartamento de Nutrição, UFPR, Curitiba, PR, Brasil.
Márcia Maria Marques Teles LoboDepartamento de Nutrição, UFPR, Curitiba, PR, Brasil.
Renata Costa de MirandaUniversity of Rome Tor Vergata, Rome, Italy.
Renato NisiharaLaboratório de Imunopatologia, Hospital de Clínicas, UFPR, Curitiba, PR, Brasil.
Maria Eliana Madalozzo SchieferdeckerDepartamento de Nutrição, UFPR, Curitiba, PR, Brasil.
César L BoguszewskiServiço de Endocrinologia e Metabologia (SEMPR), Departamento de Medicina Interna, UFPR, Curitiba, PR, Brasil.
Universidade Federal do Paraná · BRHospital de Clínicas · UYUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe objectives of this study were to evaluate the serum levels of adipokines in women with fibromyalgia with and without overweight/obesity, and to correlate the adipokines levels with clinical parameters associated with fibromyalgia and adipose tissue mass (body fat). SUBJECTS AND

methodsThe study included 100 women divided into four groups: (a) fibromyalgia and overweight/obesity; (b) fibromyalgia and normal weight; (c) controls and overweight/obesity; and (d) controls and normal weight. Patients and controls were evaluated for clinical, anthropometric, and fibromyalgia-related parameters. Assessments included serum levels of leptin, adiponectin, monocyte chemoattractant protein-1 (MCP-1), and C-reactive protein (CRP). Levels of adipokines were further adjusted for fat mass.

resultsFibromyalgia patients with overweight/obesity or normal weight had no differences in clinical parameters. Unadjusted leptin levels were lower in fibromyalgia patients than controls, a finding that was more remarkable in fibromyalgia patients with overweight/obesity. Leptin levels had no correlation with clinical parameters of fibromyalgia or inflammation markers (MCP-1 and CRP), and adiponectin levels showed no difference between groups.

conclusionsNo correlation was observed between adjusted leptin levels and clinical parameters of fibromyalgia. Patients with fibromyalgia and overweight/obesity presented lower levels of leptin than controls with overweight/obesity.

Indexed as

AdiponectinAdultBiomarkersBody Mass IndexCase-Control StudiesChemokine CCL2C-Reactive ProteinFemaleFibromyalgiaHumansLeptinMiddle AgedOverweightPain ThresholdQuality of LifeReference ValuesAdiponectinBiomarkersCCL2 protein, humanChemokine CCL2C-Reactive ProteinLeptin

Identifiers

PMID28226002
PMCPMC10118809
OpenAlexW2588918534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.